Dissecting PARP inhibitor resistance with functional genomics. [electronic resource]
- Current opinion in genetics & development 02 2019
- 55-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1879-0380
10.1016/j.gde.2019.03.001 doi
BRCA1 Protein--genetics BRCA2 Protein--genetics Breast Neoplasms--drug therapy Drug Resistance, Neoplasm--genetics Female Germ-Line Mutation--genetics Humans Ovarian Neoplasms--drug therapy Phthalazines--therapeutic use Piperazines--therapeutic use Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use Poly(ADP-ribose) Polymerases--genetics